Lv1
30 积分 2025-12-15 加入
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma
2个月前
已完结
Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
2个月前
已完结
Inhaled Reliever Therapies for Asthma
2个月前
已完结
Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts
2个月前
已完结
The immunology of asthma
2个月前
已完结
Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome
2个月前
已完结
Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema
2个月前
已关闭
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials
2个月前
已完结
嗜酸性肉芽肿性多血管炎诊治多学科专家共识(2025年版)
2个月前
已完结